lunes, 29 de octubre de 2012

Clinical applications of gene-based risk predict... [Front Genet. 2012] - PubMed - NCBI

Clinical applications of gene-based risk predict... [Front Genet. 2012] - PubMed - NCBI

Front Genet. 2012;3:210. doi: 10.3389/fgene.2012.00210. Epub 2012 Oct 16.

Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.


Faculty of Medical and Health Sciences, and Biological Sciences, University of Auckland Auckland, New Zealand.


Lung cancer is the leading cause of cancer death worldwide and nearly 90% of cases are attributable to smoking. Quitting smoking and early diagnosis of lung cancer, through computed tomographic screening, are the only ways to reduce mortality from lung cancer. Recent epidemiological studies show that risk prediction for lung cancer is optimized by using multivariate risk models that include age, smoking exposure, history of chronic obstructive pulmonary disease (COPD), family history of lung cancer, and body mass index. It has also been shown that COPD predates lung cancer in 65-70% of cases, conferring a four- to sixfold greater risk of lung cancer compared to smokers with normal lung function. Genome-wide association studies of smokers have identified a number of genetic variants associated with COPD or lung cancer. In a case-control study, where smokers with normal lungs were compared to smokers who had spirometry-defined COPD or histology confirmed lung cancer, several of these variants were shown to overlap, conferring the same susceptibility or protective effects on both COPD and lung cancer (independent of COPD status). In this perspective article, we show how combining clinical data with genetic variants can help identify heavy smokers at the greatest risk of lung cancer. Using this approach, we found that gene-based risk testing helped engage smokers in risk mitigating activities like quitting smoking and undertaking lung cancer screening. We suggest that such an approach could facilitate the targeted selection of smokers for cost-effective life-saving interventions.





Free PMC Article

No hay comentarios:

Publicar un comentario